Rigidity of nonnegatively curved compact quaternionic-Kähler manifolds

B. Chow,Deane Yang

DOI: https://doi.org/10.4310/JDG/1214442880

Abstract:Soit M une variete de Kahler compacte quaternionique a courbure bisectionnelle quaternionique positive (non negative). Alors M est HP n avec la metrique standard (un espace symetrique quaternionique)

What problem does this paper attempt to address?

Modeling contagion in policy systems

Herschel F. Thomas

DOI: https://doi.org/10.1016/j.cogsys.2017.03.003

IF: 4.541

2017-08-01

Cognitive Systems Research

Abstract:
Genome-Editing Technologies: Principles and Applications.

Jia Liu,S. Sirk,Sailan Shui,T. Gaj

DOI: https://doi.org/10.1101/cshperspect.a023754

IF: 7.2

2016-12-01

Cold Spring Harbor Perspectives in Biology

Abstract:Targeted nucleases have provided researchers with the ability to manipulate virtually any genomic sequence, enabling the facile creation of isogenic cell lines and animal models for the study of human disease, and promoting exciting new possibilities for human gene therapy. Here we review three foundational technologies-clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), and zinc-finger nucleases (ZFNs). We discuss the engineering advances that facilitated their development and highlight several achievements in genome engineering that were made possible by these tools. We also consider artificial transcription factors, illustrating how this technology can complement targeted nucleases for synthetic biology and gene therapy.

Biology,Engineering,Medicine
Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Weilin Zhou,Jinrong Yang,Yalan Zhang,Xiaoyi Hu,Wei Wang

DOI: https://doi.org/10.1002/mco2.155

2022-07-20

MedComm

Abstract:The expanding gene‐editing toolbox has driven a biomedical revolution. These molecular tools tremendously contribute to the progression of fundamental research, such as epigenetics, drug development, disease modeling, and disease diagnosis. Furthermore, therapeutic gene editing offers a profound opportunity to improve the current treatment of human diseases. The expanding genome editing toolbox has revolutionized life science research ranging from the bench to the bedside. These "molecular scissors" have offered us unprecedented abilities to manipulate nucleic acid sequences precisely in living cells from diverse species. Continued advances in genome editing exponentially broaden our knowledge of human genetics, epigenetics, molecular biology, and pathology. Currently, gene editing‐mediated therapies have led to impressive responses in patients with hematological diseases, including sickle cell disease and thalassemia. With the discovery of more efficient, precise and sophisticated gene‐editing tools, more therapeutic gene‐editing approaches will enter the clinic to treat various diseases, such as acquired immunodeficiency sydrome (AIDS), hematologic malignancies, and even severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. These initial successes have spurred the further innovation and development of gene‐editing technology. In this review, we will introduce the architecture and mechanism of the current gene‐editing tools, including clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR‐associated nuclease‐based tools and other protein‐based DNA targeting systems, and we summarize the meaningful applications of diverse technologies in preclinical studies, focusing on the establishment of disease models and diagnostic techniques. Finally, we provide a comprehensive overview of clinical information using gene‐editing therapeutics for treating various human diseases and emphasize the opportunities and challenges.
Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Jiali Pu,David Frescas,Baorong Zhang,Jian Feng

DOI: https://doi.org/10.1177/1535370215584932

2015-01-01

Experimental Biology and Medicine

Abstract:The capability to modify the genome precisely and efficiently offers an extremely useful tool for biomedical research. Recent developments in genome editing technologies such as transcription activator-like effector nuclease and the clustered regularly interspaced short palindromic repeats system have made genome modification available for a number of organisms with relative ease. Here, we introduce these genome editing techniques, compare and contrast each technical approach and discuss their potential to study the underlying mechanisms of human disease using patient-derived induced pluripotent stem cells.
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology

Mike Broeders,Pablo Herrero-Hernandez,Martijn P.T. Ernst,Ans T. van der Ploeg,W.W.M. Pim Pijnappel

DOI: https://doi.org/10.1016/j.isci.2019.100789

IF: 5.8

2020-01-01

iScience

Abstract:The ability to precisely modify human genes has been made possible by the development of tools such as meganucleases, zinc finger nucleases, TALENs, and CRISPR/Cas. These now make it possible to generate targeted deletions, insertions, gene knock outs, and point variants; to modulate gene expression by targeting transcription factors or epigenetic machineries to DNA; or to target and modify RNA. Endogenous repair mechanisms are used to make the modifications required in DNA; they include non-homologous end joining, homology-directed repair, homology-independent targeted integration, microhomology-mediated end joining, base-excision repair, and mismatch repair. Off-target effects can be monitored using in silico prediction and sequencing and minimized using Cas proteins with higher accuracy, such as high-fidelity Cas9, enhanced-specificity Cas9, and hyperaccurate Cas9. Alternatives to Cas9 have been identified, including Cpf1, Cas12a, Cas12b, and smaller Cas9 orthologs such as CjCas9. Delivery of gene-editing components is performed ex vivo using standard techniques or in vivo using AAV, lipid nanoparticles, or cell-penetrating peptides. Clinical development of gene-editing technology is progressing in several fields, including immunotherapy in cancer treatment, antiviral therapy for HIV infection, and treatment of genetic disorders such as β-thalassemia, sickle cell disease, lysosomal storage disorders, and retinal dystrophy. Here we review these technological advances and the challenges to their clinical implementation.

multidisciplinary sciences
Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

Nannan Zheng,Liyang Li,Xiangdong Wang

DOI: https://doi.org/10.1002/ctm2.34

IF: 8.554

2020-03-01

Clinical and Translational Medicine

Abstract:Methodologies of genome editing are rapidly developing with the improvement of gene science and technology, mechanism-based understanding, and urgent needs. In addition to the specificity and efficiency of on-target sites, one of the most important issues is to find and avoid off-targets before clinical application of gene editing as a therapy. Various algorithms, modified nucleases, and delivery vectors are developed to localize and minimize off-target sites. The present review aimed to clarify off-targets of various genome editing and explore potentials of clinical application by understanding structures, mechanisms, clinical applications, and off-target activities of genome editing systems, including CRISPR/Cas9, CRISPR/Cas12a, zinc finger nucleases, transcription activator-like effector nucleases, meganucleases, and recent developments. Current genome editing in cancer therapy mainly targeted immune systems in tumor microenvironment by ex vivo modification of the immune cells in phases I/II of clinical trials. We believe that genome editing will be the critical part of clinical precision medicine strategy and multidisciplinary therapy strategy by integrating gene sequencing, clinical transomics, and single cell biomedicine. There is an urgent need to develop on/off-target-specific biomarkers to monitor the efficacy and side-effects of gene therapy. Thus, the genome editing will be an alternative of clinical therapies for cancer with the rapid development of methodology and an important part of clinical precision medicine strategy.

oncology,medicine, research & experimental
Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Qinya Liu,Qianyuan Sun,Jiajun Yu

DOI: https://doi.org/10.62051/e47ayw75

2024-03-24

Abstract:At present, the main gene editing tools encompass TREN, Zinc Finger Nucleases (ZFN), clustered regularly interspaced short palindromic repeats (CRISPR), and Transcription Activator-Like Effector Nucleases (TALEN). In this study, we introduce an overview of the three gene editing methodologies and discuss their current clinical applications. In addition, we suggest some trends and future applications within the field of gene editing. ZFNs represent one of the pioneering technologies, demonstrating significant efficacy in mitigating a multitude of genetic diseases and finding applications in agriculture. Yet, this technology contains intricate processes and produces substantial costs when implemented. TALENs have already been employed across various domains. In the medical field, they have been successfully applied in the treatment of leukemia in infants. However, TALENs are being replaced by CRISPR due to the superior efficiency of CRISPR. CRISPR, consisting of six components, exhibits considerable promise in the medical realm, particularly in the context of treating diseases such as Alzheimer's disease (AD). In the realm of genetic engineering, it can collaborate with B cells to rectify specific genes within the human genome, which have been tested in experiments. In the future, it can be used in many fields, including agriculture and nucleic acid testing.
Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Jiali Pu,David Frescas,Baorong Zhang,Jian Feng

DOI: https://doi.org/10.1177/1535370215584932

2015-01-01

Experimental Biology and Medicine

Abstract:The capability to modify the genome precisely and efficiently offers an extremely useful tool for biomedical research. Recent developments in genome editing technologies such as transcription activator-like effector nuclease and the clustered regularly interspaced short palindromic repeats system have made genome modification available for a number of organisms with relative ease. Here, we introduce these genome editing techniques, compare and contrast each technical approach and discuss their potential to study the underlying mechanisms of human disease using patient-derived induced pluripotent stem cells.
CRISPR-Cas9: A Precise Approach to Genome Engineering

Jorge E Simón,Ángel S Rodríguez,Nelson Santiago Vispo

DOI: https://doi.org/10.1177/2168479018762798

Abstract:In the last few decades, genomic manipulation has made significant progress as a result of the development of recombinant DNA technologies; however, more often than not, these techniques have been costly and labor intensive. In contrast, recently developed next-generation sequencing (NGS) technologies have provided a cheaper, faster, and easier process to study genomics. In particular, an NGS technique emerged from bacterial CRISPR-associated protein-9 nuclease (Cas9) as a revolutionary method to modify, regulate, or mark specific genomic sequences on virtually any organism. A later adaptation of this bacterial defense mechanism that successfully and permanently edits dysfunctional genes and corrects missing proteins has resulted in a new era for disease genetic engineering. Clinical trials using this technique are already being performed, and the applicability of CRISPR-Cas9 techniques is actively being investigated using in vivo studies. However, the concept of genome correction poses great concerns from a regulatory perspective, especially in terms of security, so principles for the regulation of these methodologies are being established. We delved into CRISPR-Cas9 from its natural and ortholog origins to its engineered variants and behaviors to present its notable and diverse applications in the fields of biotechnology and human therapeutics.
Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Cia-Hin Lau,Qing-Le Liang,Haibao Zhu

DOI: https://doi.org/10.1007/s11248-024-00404-x

2024-08-22

Transgenic Research

Abstract:The application of rapidly growing CRISPR toolboxes and methods has great potential to transform biomedical research. Here, we provide a snapshot of up-to-date CRISPR toolboxes, then critically discuss the promises and hurdles associated with CRISPR-based nuclear genome editing, epigenome editing, and mitochondrial editing. The technical challenges and key solutions to realize epigenome editing in vivo, in vivo base editing and prime editing, mitochondrial editing in complex tissues and animals, and CRISPR-associated transposases and integrases in targeted genomic integration of very large DNA payloads are discussed. Lastly, we discuss the latest situation of the CRISPR/Cas9 clinical trials and provide perspectives on CRISPR-based gene therapy. Apart from technical shortcomings, ethical and societal considerations for CRISPR applications in human therapeutics and research are extensively highlighted.

biochemistry & molecular biology,biochemical research methods,biotechnology & applied microbiology
Genome-editing Technologies for Gene and Cell Therapy

Morgan L Maeder,Charles A Gersbach

DOI: https://doi.org/10.1038/mt.2016.10

IF: 12.91

2016-03-01

Molecular Therapy

Abstract:Gene therapy has historically been defined as the addition of new genes to human cells. However, the recent advent of genome-editing technologies has enabled a new paradigm in which the sequence of the human genome can be precisely manipulated to achieve a therapeutic effect. This includes the correction of mutations that cause disease, the addition of therapeutic genes to specific sites in the genome, and the removal of deleterious genes or genome sequences. This review presents the mechanisms of different genome-editing strategies and describes each of the common nuclease-based platforms, including zinc finger nucleases, transcription activator-like effector nucleases (TALENs), meganucleases, and the CRISPR/Cas9 system. We then summarize the progress made in applying genome editing to various areas of gene and cell therapy, including antiviral strategies, immunotherapies, and the treatment of monogenic hereditary disorders. The current challenges and future prospects for genome editing as a transformative technology for gene and cell therapy are also discussed.

genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Hongyi Li,Yang Yang,Weiqi Hong,Mengyuan Huang,Min Wu,Xia Zhao

DOI: https://doi.org/10.1038/s41392-019-0089-y

IF: 39.3

2020-01-03

Signal Transduction and Targeted Therapy

Abstract:Abstract Based on engineered or bacterial nucleases, the development of genome editing technologies has opened up the possibility of directly targeting and modifying genomic sequences in almost all eukaryotic cells. Genome editing has extended our ability to elucidate the contribution of genetics to disease by promoting the creation of more accurate cellular and animal models of pathological processes and has begun to show extraordinary potential in a variety of fields, ranging from basic research to applied biotechnology and biomedical research. Recent progress in developing programmable nucleases, such as zinc-finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs) and clustered regularly interspaced short palindromic repeat (CRISPR)–Cas-associated nucleases, has greatly expedited the progress of gene editing from concept to clinical practice. Here, we review recent advances of the three major genome editing technologies (ZFNs, TALENs, and CRISPR/Cas9) and discuss the applications of their derivative reagents as gene editing tools in various human diseases and potential future therapies, focusing on eukaryotic cells and animal models. Finally, we provide an overview of the clinical trials applying genome editing platforms for disease treatment and some of the challenges in the implementation of this technology.

biochemistry & molecular biology,cell biology
Gene Editing Technology and Ethical Issues

Barbara Jane Holland

DOI: https://doi.org/10.4018/978-1-7998-3479-3.ch136

2021-01-01

Abstract:CRISPR (clustered regularly interspaced short palindromic repeats) technology has emerged as a powerful technology for genome editing and is now widely used in basic biomedical research to explore gene function. More recently, this technology has been increasingly applied to the study or treatment of human diseases. CRISPR/Cas9 gene editing has also been applied in immunology-focused applications such as the targeting of C-C chemokine receptor type 5, the programmed death 1 gene and the creation of chimeric antigen receptors in T cells for purposes such as the treatment of the acquired immune deficiency syndrome (AIDS) or promoting anti-tumor immunotherapy. Furthermore, scientist recently suggest through their study that CRISPR may not work for everyone. This paper will review gene editing technology and its ethical concerns.
Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects

Kuldeep Singh,Bharat Bhushan,Sunil Kumar,Supriya Singh,Romulo R Macadangdang,Ekta Pandey,Ajit Kumar Varma,Shivendra Kumar,Romulo R. Macadangdang, Jr

DOI: https://doi.org/10.2174/0115665232279528240115075352

2024-03-19

Current Gene Therapy

Abstract:Precision genome editing is a rapidly evolving field in gene therapy, allowing for the precise modification of genetic material. The CRISPR and Cas systems, particularly the CRISPR-- Cas9 system, have revolutionized genetic research and therapeutic development by enabling precise changes like single-nucleotide substitutions, insertions, and deletions. This technology has the potential to correct disease-causing mutations at their source, allowing for the treatment of various genetic diseases. Programmable nucleases like CRISPR-Cas9, transcription activator-like effector nucleases (TALENs), and zinc finger nucleases (ZFNs) can be used to restore normal gene function, paving the way for novel therapeutic interventions. However, challenges, such as off-target effects, unintended modifications, and ethical concerns surrounding germline editing, require careful consideration and mitigation strategies. Researchers are exploring innovative solutions, such as enhanced nucleases, refined delivery methods, and improved bioinformatics tools for predicting and minimizing off-target effects. The prospects of precision genome editing in gene therapy are promising, with continued research and innovation expected to refine existing techniques and uncover new therapeutic applications.

genetics & heredity
Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

Hua Alexander Han,Jeremy Kah Sheng Pang,Boon-Seng Soh

DOI: https://doi.org/10.1007/s00109-020-01893-z

2020-03-20

Journal of Molecular Medicine

Abstract:Abstract The rapid advancement of genome editing technologies has opened up new possibilities in the field of medicine. Nuclease-based techniques such as the CRISPR/Cas9 system are now used to target genetically linked disorders that were previously hard-to-treat. The CRISPR/Cas9 gene editing approach wields several advantages over its contemporary editing systems, notably in the ease of component design, implementation and the option of multiplex genome editing. While results from the early phase clinical trials have been encouraging, the small patient population recruited into these trials hinders a conclusive assessment on the safety aspects of the CRISPR/Cas9 therapy. Potential safety concerns include the lack of fidelity in the CRISPR/Cas9 system which may lead to unintended DNA modifications at non-targeted gene loci. This review focuses modifications to the CRISPR/Cas9 components that can mitigate off-target effects in in vitro and preclinical models and its translatability to gene therapy in patient populations.

genetics & heredity,medicine, research & experimental
CRISPR/Cas9 Technology: Challenges and drawbacks

Ayan Ghorui, Sibashish Baksi

DOI: https://doi.org/10.17762/jaz.v44is6.2680

2023-12-11

Journal Of Advanced Zoology

Abstract:Genome engineering has been transformed in recent years by the introduction of the CRISPR technology for a variety of cancer research projects spanning from fundamental science to translational medicine and precision cancer treatment. Although there have been tremendous advancements in this area, a number of technical issues still need to be resolved, including off- target activity, inadequate indel or poor homology-directed repair (HDR) efficiency, in vivo distribution of the Cas system components, and immunological reactions. Chromosome rearrangements brought on by off-target effects might unintentionally affect some poorly matched genomic locations and restrict the use of CRISPR-Cas editing technologies for therapeutic reasons. Studies have shown that CRISPR-Cas tools may be more susceptible to off-target effects than some of the other common gene-editing techniques because a Cas protein is a monomer that might accidentally enhance the identification of shorter target sequences, whereas the TALEN and ZFN assemblies are dimeric. Off-target effects often come from Cas enzymes that cleave bystanders (not intended targets) and guide RNA to recognize mismatches. CRISPR systems delivered in vivo can trigger immune responses against foreign substances by significantly increasing people's innate immunity and/or adaptive immunity. Guide RNAs may be used to initiate innate immune responses. This article provides an overview of CRISPR-Cas applications from the lab to the clinic, identifies current barriers that may restrict the use of CRISPR-Cas systems as gene-editing toolkits in precision medicine, and offers some perspectives on how to address these barriers and speed up technical advancement
Gene Editing and Its Applications in Biomedicine

Li Guanglei,Li Xiangyang,Zhuang Songkuan,Wang Liren,Zhu Yifan,Chen Yangcan,Sun Wen,Wu Zeguang,Zhou Zhuo,Chen Jia,Huang Xingxu,Wang Jin,Li Dali,Li Wei,Wang Haoyi,Wei Wensheng

DOI: https://doi.org/10.1007/s11427-021-2057-0

2022-01-01

Abstract:The steady progress in genome editing, especially genome editing based on the use of clustered regularly interspaced short palindromic repeats (CRISPR) and programmable nucleases to make precise modifications to genetic material, has provided enormous opportunities to advance biomedical research and promote human health. The application of these technologies in basic biomedical research has yielded significant advances in identifying and studying key molecular targets relevant to human diseases and their treatment. The clinical translation of genome editing techniques offers unprecedented biomedical engineering capabilities in the diagnosis, prevention, and treatment of disease or disability. Here, we provide a general summary of emerging biomedical applications of genome editing, including open challenges. We also summarize the tools of genome editing and the insights derived from their applications, hoping to accelerate new discoveries and therapies in biomedicine.
An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications

Fatima Akram,Sania Sahreen,Farheen Aamir,Ikram ul Haq,Kausar Malik,Memoona Imtiaz,Waqas Naseem,Narmeen Nasir,Hafiza Mariam Waheed

DOI: https://doi.org/10.1007/s12033-022-00501-4

2022-04-26

Molecular Biotechnology

Abstract:Genome-editing technology has enabled scientists to make changes in model organisms' DNA at the genomic level to get biotechnologically important products from them. Most commonly employed technologies for this purpose are transcription activator like effector nucleases (TALENs), homing-endonucleases or meganucleases, zinc finger nucleases (ZFNs), and clustered regularly interspaced short palindromic repeats (CRISPR) associated protein 9 (Cas9). Among these tools, CRISPR/Cas9 is most preferred because it's easy to use, has a small mutation rate, has great effectiveness, low cost of development, and decreased rate of advancement. CRISPR/Cas9 has a lot of applications in plants, animals, humans, and microbes. It also has applications in many fields such as horticulture, cancer, food biotechnology, and targeted human genome treatments. CRISPR technology has shown great potential for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to provide early and easy detection methods, possible treatment, and vaccine development. In the present review, genome-editing tools with their basic assembly and features have been discussed. Exceptional notice has been paid to CRISPR technology on basis of its structure and significant applications in humans, plants, animals, and microbes such as bacteria, viruses, and fungi. The review has also shed a little light on current CRISPR challenges and future perspectives.

biochemistry & molecular biology,biotechnology & applied microbiology
CRISPR technologies for genome, epigenome and transcriptome editing

Lukas Villiger,Julia Joung,Luke Koblan,Jonathan Weissman,Omar O. Abudayyeh,Jonathan S. Gootenberg

DOI: https://doi.org/10.1038/s41580-023-00697-6

IF: 113.915

2024-02-03

Nature Reviews Molecular Cell Biology

Abstract:Our ability to edit genomes lags behind our capacity to sequence them, but the growing understanding of CRISPR biology and its application to genome, epigenome and transcriptome engineering is narrowing this gap. In this Review, we discuss recent developments of various CRISPR-based systems that can transiently or permanently modify the genome and the transcriptome. The discovery of further CRISPR enzymes and systems through functional metagenomics has meaningfully broadened the applicability of CRISPR-based editing. Engineered Cas variants offer diverse capabilities such as base editing, prime editing, gene insertion and gene regulation, thereby providing a panoply of tools for the scientific community. We highlight the strengths and weaknesses of current CRISPR tools, considering their efficiency, precision, specificity, reliance on cellular DNA repair mechanisms and their applications in both fundamental biology and therapeutics. Finally, we discuss ongoing clinical trials that illustrate the potential impact of CRISPR systems on human health.

cell biology
A review on molecular scissoring with CRISPR/Cas9 genome editing technology

Muskan Irfan,Hammad Majeed,Tehreema Iftikhar,Pritam Kumar Ravi

DOI: https://doi.org/10.1093/toxres/tfae105

2024-07-12

Abstract:Genome editing is a technology to make specific changes in the DNA of a cell or an organism. It has significantly altered the landscape of life sciences, facilitating the establishment of exceedingly customized genetic modifications. Among various genome editing technologies, the CRISPR/Cas9 system, a specific endonuclease induces a double stranded DNA break and enabling modifications to the genome, has surfaced as a formidable and adaptable instrument. Its significance cannot be overstated, as it not only allows for the manipulation of genomes in model organisms but also holds great potential for revolutionary advances in medicine, particularly in treating genetic diseases. This review paper explores the remarkable journey of CRISPR/Cas9, its natural function, mechanisms, and transformative impact on genome editing and finally the use of artificial intelligence and other intelligent manufacturing tools used. The introduction provides the background on genome editing, emphasizing the emergence and significance of CRISPR/Cas9. Subsequent sections comprehensively elucidate its natural function, disease modeling, agriculture, and biotechnology, address therapeutic applications, and ongoing clinical trials while also discussing prospects and ethical implications. We summarized the key findings, indicating that CRISPR/Cas9 has empowered the creation of disease-specific animal models. This provides invaluable insights into pathogenic mechanisms and opens new avenues for drug discovery, reaffirming the transformative impact of CRISPR/Cas9 on genome editing. Finally we discussed the importance of continued research and collaboration for comprehensive utilization of the inherent capabilities of this molecular precision tool in shaping forthcoming advancements.

Rigidity of nonnegatively curved compact quaternionic-Kähler manifolds

Modeling contagion in policy systems

Genome-Editing Technologies: Principles and Applications.

Current landscape of gene‐editing technology in biomedicine: Applications, advantages, challenges, and perspectives

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Sharpening the Molecular Scissors: Advances in Gene-Editing Technology

Molecular mechanisms, off‐target activities, and clinical potentials of genome editing systems

Gene Editing's Sharp Edge: Understanding Zinc Finger Nucleases (ZFN), Transcription Activator-Like Effector Nucleases (TALEN) and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

CRISPR-Cas9: A Precise Approach to Genome Engineering

Next-generation CRISPR technology for genome, epigenome and mitochondrial editing

Genome-editing Technologies for Gene and Cell Therapy

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Gene Editing Technology and Ethical Issues

Precision Genome Editing Techniques in Gene Therapy: Current State and Future Prospects

Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing

CRISPR/Cas9 Technology: Challenges and drawbacks

Gene Editing and Its Applications in Biomedicine

An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its Applications

CRISPR technologies for genome, epigenome and transcriptome editing

A review on molecular scissoring with CRISPR/Cas9 genome editing technology